28-Jul-2015 El País La autora expone la preocupación de Médicos sin Fronteras por la disponibilidad futura de medicamentos y vacunas asequibles debido al acuerdo comercial entre EE UU y 11 países.
Nearly two-thirds of Canadians oppose longer patents for brand-name drugs under a proposed trade deal with the European Union, according to a poll commissioned by the Council of Canadians.
12-Dec-2013 IP Watch
Following the public outcry over the EU’s demands for stringent intellectual property rules that would dramatically raise medicines prices in India, you would expect the EU to think twice about making similar demands in future trade agreements. Yet, this is precisely what is going on now in the negotiations for a free trade agreement between the EU and Thailand.
11-Dec-2013 Tribune de Genève
Bruxelles n’a pas accepté la politique de licence que défend New Delhi, principalement dans la pharma. C’est précisément ce point —la protection de la propriété intellectuelle— qui inquiète la branche en Suisse.
11-Dec-2013 Financial Chronicle
There are apprehensions that TTIP would prevent Indian pharma companies to come to market with the same products - they would need to pass through several rounds of additional tests. As a result, prices will move up significantly.
Leaked details of free trade negotiations between New Zealand and the United States show the two countries are in stark opposition on a number of key areas.
Since announcing the Comprehensive Economic and Trade Agreement (CETA) two weeks ago Harper’s Conservatives have repeatedly labelled those questioning the deal as “anti-trade”. But this Canada-European Union accord is one part trade and four parts ‘corporate bill of rights’.
The federal government won’t release internal documents that may predict potential higher drug costs for Canadians under new patent rules agreed to in the free-trade deal with Europe, Trade Minister Ed Fast says.
The far reaching provisions of the Comprehensive Economic and Trade Agreement between Canada and the European Union will have considerable impact on Canada’s IP regime.
18-Oct-2013 Radio Canada
Ottawa, comme d’autres provinces canadiens, exigera des compensations financières pour certains de ses secteurs économiques qui risquent de souffrir du nouvel accord de libre-échange entre le Canada et l’Union européenne.
2-Oct-2013 Dissent Magazine
The struggle for access to medicine presents a legal and ethical minefield for rich and poor countries alike—one that is being fought out as humanitarians challenge corporations over intellectual property rights.
US puts unwarranted pressure on India for taking legal steps to increase access to affordable medicines
India is facing an onslaught of political pressure from the U.S. government and pharmaceutical industry in retaliation for the country’s entirely legal actions to limit abusive patenting practices and increase access to affordable generic medicines
18-Sep-2013 ACT UP Paris
Communiqué de presse interassociatif (Act Up-Paris, HAI, Oxfam, Action against AIDS)
16-Sep-2013 Bangkok Post
Thai trade representative Olarn Chaiprawat has given civil society groups a confirmation that "TRIPS-plus" and drug issues will not be included in the Thai-EU FTA negotiations.
Once again, our government is negotiating a trade deal in secret — and once again, the chorus of “free market” fundamentalists is assuring us that what’s good for lining corporate pockets must be good for us all.
Malaysia should exclude medical and tobacco businesses in the ongoing free trade talks under the Trans-Pacific Partnership Agreement (TPPA).
Alianza LAC - Global por el Acceso a Medicamentos: el TPP amenaza el acceso a medicamentos asequibles
"Rechazamos y denunciamos la falta de transparencia en la que se desarrollan las negociaciones, constituyendo un proceso nada democrático, sin participación de los parlamentos nacionales ni de la sociedad civil. El futuro de alrededor de 700 millones de personas no se puede negociar en secreto."
Canada is pushing back against a campaign by activists trying to block what they say are onerous intellectual property rules that would raise the price of pharmaceuticals in poor countries.
3-Jul-2013 Programa de las Américas
¿Qué significa realmente el TPP (Asociación del Transpacífico) para América Latina?
As host to both the AIDS conference and TPP trade talks this month, Malaysia reportedly vows to reject a TPP trade agreement that harms access to medicines; other countries should follow suit, and Malaysia should be held to its pledge
30-Jun-2013 South Centre
Bilateral investment treaties (BITs) may be a threat to access to medicines as shown by a recent legal suit by a drug multinational against Canada for invalidating a patent, writes Carlos Correa